Evidence map›Paper›PMID 31067122›Full record

ArticleAIDS patient care and STDs2019

Recent HIV Risk Behavior and Partnership Type Predict HIV Pre-Exposure Prophylaxis Adherence in Men Who Have Sex with Men.

Jill Blumenthal, David J Moore, Sonia Jain, Xiaoying Sun, Eric Ellorin, Katya Corado, Martin Hoenigl, Michael Dube, Richard Haubrich, Sheldon R Morris

Abstract read
In one paragraph

Article in AIDS patient care and STDs, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jill Blumenthal1 Department of Medicine, University of California San Diego, La Jolla, California.
David J Moore1 Department of Medicine, University of California San Diego, La Jolla, California.
Sonia Jain1 Department of Medicine, University of California San Diego, La Jolla, California.
Xiaoying Sun1 Department of Medicine, University of California San Diego, La Jolla, California.
Eric Ellorin1 Department of Medicine, University of California San Diego, La Jolla, California.
Katya Corado2 Department of Psychiatry, University of California San Diego, La Jolla, California.
Martin Hoenigl1 Department of Medicine, University of California San Diego, La Jolla, California.
Michael Dube3 Department of Family Medicine and Public Health, University of California San Diego, La Jolla, California.
Richard Haubrich4 Department of Medicine, Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, Torrance, California.
Sheldon R Morris1 Department of Medicine, University of California San Diego, La Jolla, California.

Funding

UC San Diego Clinical and Translational Research InstituteUL1TR001442 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S, HOGARTH, MICHAEL · 2015 to 2024
$88.3M
VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SUSAN JANET LITTLE · 1994 to 2026
$78.4M
UC San Diego Clinical and Translational Research InstituteKL2TR001444 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DEPP, COLIN A. · 2015 to 2024
$15.4M
Improving Antiretroviral Management for HIVK24AI064086 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HAUBRICH, RICHARD H · 2006 to 2015
$1.8M
NCATS NIH HHS KL2 TR001444NCATS NIH HHS UL1 TR001442NIAID NIH HHS K24 AI064086NIAID NIH HHS P30 AI036214
6 · The paper itself

Abstract

Men who have sex with men (MSM) reporting higher HIV risk behavior over time are often more adherent to pre-exposure prophylaxis (PrEP), but it is unclear if recent risk behavior and partnership type affect long-term PrEP adherence. HIV-negative MSM and transgender women completing the 48-week randomized study TAPIR (Daily Text Messages to Support Adherence to PrEP in At-Risk for HIV Individuals) were included. At baseline and weeks 24 and 48, a modified Calculated Risk (mCalcR) Score estimated the likelihood of HIV seroconversion over 1 year based on reported condomless anal sex acts in the last month and current sexually transmitted infection. mCalcR scores were categorized as low, moderate, and high/very high risk. Partnership type was classified as no partner/single HIV-negative partner (no/single-), single HIV-positive partner (single+), or multiple partners of any serostatus (multi) in the past 3 months. PrEP adherence was measured by intracellular tenofovir-diphosphate (TFV-DP) levels. Among 313 individuals, there was no difference in mCalcR category from baseline to week 48. There was a significant change in partnership type, with no/single partnerships increasing from 0.5% to 9%. Participants with moderate and high/very risk had higher TFV-DP levels than the low-risk group. No/single participants had lower TFV-DP levels than those reporting single+ or multi. Although there was a shift toward lower-risk partnerships, HIV risk category remained stable over time. Individuals with riskier behaviors and partnerships had higher PrEP drug levels, suggesting continued motivation for and adherence to PrEP.

Indexed as

Risk-TakingSexual PartnersAdultAnti-HIV AgentsFemaleHIV InfectionsHomosexuality, MaleHumansMaleMedication AdherenceMiddle AgedPre-Exposure ProphylaxisTenofovirYoung AdultAnti-HIV AgentsTenofovirHIV preventionHIV riskmedication adherencemen who have sex with men (MSM)partnershipspre-exposure prophylaxis (PrEP)

Identifiers

PMID31067122
PMCPMC6531901

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.